Targeting Enhancer of Zeste Homolog 2 as a promising strategy for cancer treatment
about
Structural insights into conformational stability of both wild-type and mutant EZH2 receptorA Novel Role of Silibinin as a Putative Epigenetic Modulator in Human Prostate Carcinoma.DNA methylation profiling reveals common signatures of tumorigenesis and defines epigenetic prognostic subtypes of canine Diffuse Large B-cell Lymphoma.Expression of EZH2 in uveal melanomas patients and associations with prognosis.12-O-tetradecanoylphorbol-13-acetate and EZH2 inhibition: A novel approach for promoting myogenic differentiation in embryonal rhabdomyosarcoma cells.
P2860
Targeting Enhancer of Zeste Homolog 2 as a promising strategy for cancer treatment
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Targeting Enhancer of Zeste Homolog 2 as a promising strategy for cancer treatment
@en
type
label
Targeting Enhancer of Zeste Homolog 2 as a promising strategy for cancer treatment
@en
prefLabel
Targeting Enhancer of Zeste Homolog 2 as a promising strategy for cancer treatment
@en
P2860
P356
P1476
Targeting Enhancer of Zeste Homolog 2 as a promising strategy for cancer treatment
@en
P2093
Luigi Bagella
P2860
P304
P356
10.5306/WJCO.V7.I2.135
P577
2016-04-01T00:00:00Z